Andrew Faughnan | Director of IR |
John Crowley | Chairman & CEO |
Bradley Campbell | President & COO |
Mitch Goldman | SVP of Clinical Research |
Jeff Castelli | Chief Development Officer |
Daphne Quimi | CFO |
Hung Do | Chief Science Officer |
Anupam Rama | JPMorgan |
Ritu Baral | Cowen |
Joseph Schwartz | SVB Leerink |
Salveen Richter | Goldman Sachs |
Mike Ulz | Baird |
Evan Wang | Guggenheim Securities |
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Third Quarter 2020 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr.